Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of MK-3697: A selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia
Anthony J. Roecker, Thomas S. Reger, M. Christa Mattern, et al.
Bioorganic & Medicinal Chemistry Letters (2014) Vol. 24, Iss. 20, pp. 4884-4890
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia
Paul J. Coleman, Anthony L. Gotter, W. Joseph Herring, et al.
The Annual Review of Pharmacology and Toxicology (2016) Vol. 57, Iss. 1, pp. 509-533
Closed Access | Times Cited: 114
Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia
Anthony J. Roecker, Christopher D. Cox, Paul J. Coleman
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 2, pp. 504-530
Closed Access | Times Cited: 107
Recent trends in orexin research—2010 to 2015
Christoph Boss, Catherine Roch
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 15, pp. 2875-2887
Closed Access | Times Cited: 74
Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man
Anthony L. Gotter, Mark S. Forman, C. Meacham Harrell, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 72
Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia
Pascal Bonaventure, Jonathan Shelton, Sujin Yun, et al.
Journal of Pharmacology and Experimental Therapeutics (2015) Vol. 354, Iss. 3, pp. 471-482
Open Access | Times Cited: 71
Hypocretin/Orexin Receptor Pharmacology and Sleep Phases
Yu Sun, Ryan K. Tisdale, Thomas S. Kilduff
Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences (2021), pp. 22-37
Open Access | Times Cited: 42
Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical Candidate
Michael A. Letavic, Pascal Bonaventure, Nicholas I. Carruthers, et al.
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 14, pp. 5620-5636
Closed Access | Times Cited: 38
Emerging role of orexin antagonists in insomnia therapeutics: An update on SORAs and DORAs
Anil Kumar, Priyanka Chanana, Supriti Choudhary
Pharmacological Reports (2015) Vol. 68, Iss. 2, pp. 231-242
Closed Access | Times Cited: 35
Orexin OX2 Receptor Antagonists as Sleep Aids
Laura H. Jacobson, Sui Chen, Sanjida Mir, et al.
Current topics in behavioral neurosciences (2016), pp. 105-136
Open Access | Times Cited: 35
Design and Synthesis of Potent and Highly Selective Orexin 1 Receptor Antagonists with a Morphinan Skeleton and Their Pharmacologies
Hiroshi Nagase, Naoshi Yamamoto, Masahiro Yata, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 3, pp. 1018-1040
Closed Access | Times Cited: 34
Substituted pyrrolidin-2-ones: Centrally acting orexin receptor antagonists promoting sleep. Part 2
Thierry Sifferlen, Amandine Boller, Audrey Chardonneau, et al.
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 9, pp. 1884-1891
Closed Access | Times Cited: 31
Divergent Synthesis of Isoxazolo[5,4‐b]pyridines
Min Li, Wenzhe Li, Min Huang, et al.
European Journal of Organic Chemistry (2024) Vol. 27, Iss. 9
Closed Access | Times Cited: 2
Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development properties
Scott D. Kuduk, Jason W. Skudlarek, Christina N. DiMarco, et al.
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 12, pp. 2488-2492
Closed Access | Times Cited: 18
Orexin receptor antagonists – a patent review (2010 to August 2014)
Christoph Boss
Expert Opinion on Therapeutic Patents (2014) Vol. 24, Iss. 12, pp. 1367-1381
Closed Access | Times Cited: 18
Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements
Anthony J. Roecker, Swati P. Mercer, Jeffrey M. Bergman, et al.
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 21, pp. 4992-4999
Closed Access | Times Cited: 16
Oxadiazole Derivatives as Dual Orexin Receptor Antagonists: Synthesis, Structure–Activity Relationships, and Sleep‐Promoting Properties in Rats
Christine Brotschi, Catherine Roch, John Gatfield, et al.
ChemMedChem (2019) Vol. 14, Iss. 13, pp. 1257-1270
Closed Access | Times Cited: 10
Investigation of orexin-2 selective receptor antagonists: Structural modifications resulting in dual orexin receptor antagonists
Jason W. Skudlarek, Christina N. DiMarco, Kerim Babaoglu, et al.
Bioorganic & Medicinal Chemistry Letters (2017) Vol. 27, Iss. 6, pp. 1364-1370
Closed Access | Times Cited: 8
Synthesis and characterization of a novel 18F-labeled 2,5-diarylnicotinamide derivative targeting orexin 2 receptor
Hiroyuki Watanabe, Naoki Matsushita, Yoichi Shimizu, et al.
MedChemComm (2019) Vol. 10, Iss. 12, pp. 2126-2130
Open Access | Times Cited: 7
Synthesis of Fused Pyridine Carboxylates by Reaction of β-Alkoxyvinyl Glyoxylates with Amino Heterocycles
Ivan S. Kondratov, Oleksandr O. Grygorenko, Oleksandr O. Stepaniuk, et al.
Synthesis (2020) Vol. 52, Iss. 13, pp. 1915-1926
Closed Access | Times Cited: 7
Pyrazole derivatives as selective orexin-2 receptor antagonists (2-SORA): synthesis, structure–activity–relationship, and sleep-promoting properties in rats
Christine Brotschi, Martin H. Bolli, John Gatfield, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 344-354
Closed Access | Times Cited: 2
Molecular Evolutionary Analysis of the HCRTR Gene Family in Vertebrates
Zhen Cai, Hehe Liu, Liyun Wang, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-9
Open Access | Times Cited: 5
Orexin receptors in GtoPdb v.2021.3
Paul J. Coleman, Luı́s de Lecea, Anthony L. Gotter, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2021) Vol. 2021, Iss. 3
Open Access | Times Cited: 4
Orexin receptors in GtoPdb v.2023.1
Gary Aston‐Jones, Pascal Bonaventure, Paul J. Coleman, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 1
Orexin Receptor Antagonists
Brock T. Shireman, Michael A. Letavic
Elsevier eBooks (2016), pp. 225-279
Closed Access | Times Cited: 1
Orexin Receptor Antagonists
Daniël Hoyer, Laura H. Jacobson
Current Sleep Medicine Reports (2017) Vol. 3, Iss. 4, pp. 342-353
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top